Module Database Search



MODULE DESCRIPTOR
Module Title
Clinical Pharmacology And Therapeutics 1
Reference PH3130 Version 4
Created August 2021 SCQF Level SCQF 9
Approved March 2013 SCQF Points 45
Amended August 2021 ECTS Points 22.5

Aims of Module
To develop knowledge and understanding of the scientific principles and concepts of pharmacology, pharmacokinetics and evidence-based therapeutics and integration of these into therapeutic plans for individual patients.

Learning Outcomes for Module
On completion of this module, students are expected to be able to:
1 Demonstrate a critical understanding of the fundamentals of pharmacology, pharmacokinetics and evidence-based therapeutics.
2 Synthesise and justify suitable evidence-based therapeutic strategies.
3 Retrieve, evaluate, manipulate, interpret and present experimental/clinical data and information.
4 Utilise scientific principles to develop and defend therapeutic plans.

Indicative Module Content
Promoting the importance of evidence-based therapeutics, with an introduction to the skills needed to develop therapeutic plans for individual patients. Topics include: Pharmacology; mechanism of drug action; principles of pharmacodynamics and pharmacokinetics. Evidence-based therapeutics of nervous, endocrine, cardiovascular and urinary systems. Evidence-based therapeutics incluidng: setting goals of therapy, drug selection, adverse drug reactions, side effects, new therapies, monitoring and non-pharmacological management of common diseases in the above systems.

Module Delivery
Lectures, coursework sessions (including individual and group problem solving exercises and tutorial sessions) and directed study (including computer packages, directed reading, and self-assessment exercises).

Indicative Student Workload Full Time Part Time
Contact Hours 110 N/A
Non-Contact Hours 340 N/A
Placement/Work-Based Learning Experience [Notional] Hours N/A N/A
TOTAL 450 N/A
Actual Placement hours for professional, statutory or regulatory body    

ASSESSMENT PLAN
If a major/minor model is used and box is ticked, % weightings below are indicative only.
Component 1
Type: Examination Weighting: 50% Outcomes Assessed: 1, 2
Description: 1.5 hour written examination consisting of multiple-choice questions.
Component 2
Type: Examination Weighting: 50% Outcomes Assessed: 3, 4
Description: 2 hour written examination consisting of MCQ and short answer style questions on evidence-based therapeutics and case study material.

MODULE PERFORMANCE DESCRIPTOR
Explanatory Text
The first grade represents Component 1 (EX1) equally weighted with the second, Component 2 (EX2). A minimum of Module Grade D is required to pass the module. Non-submission of either component will result in an NS grade.
Module Grade Minimum Requirements to achieve Module Grade:
A AA,AB,BA
B AC,AD,BB,BC,CA,CB,DA
C BD,CC,CD,DB,DC
D DD
E AE,AF,BE,BF,CE,CF,DE,EA,EB,EC,ED,EE,FA,FB,FC
F DF,FE,FD,EF,FF
NS Non-submission of work by published deadline or non-attendance for examination

Module Requirements
Prerequisites for Module Successful completion of Stage 1 or its equivalent.
Corequisites for module None.
Precluded Modules None.

INDICATIVE BIBLIOGRAPHY
1 GOLDACRE, B. Bad Science. 1st edition 2008. London: HarperCollins
2 NEAL, M.J. Medical Pharmacology at a Glance. 9th edition. Oxford: Wiley-Blackwell recommended purchase
3 H. P. Rang, J. M. Ritter, R. J. Flower, and G. Henderson. Rang and Dale's Pharmacology. Current edition (8th Edition published Jan 2015.)Churchill Livingstone. recommended purchase
4 WALKER, R. and EDWARDS, C. Clinical Pharmacy and Therapeutics. 3rd edition. Edinburgh: Churchill Livingstone.
5 Teaching Resource Centre (TRC) Pharmacology- a free App developed by the University of Leiden (NL) for smartphones and tablets available from iTunes and Google Play.

Robert Gordon University, Garthdee House, Aberdeen, AB10 7QB, Scotland, UK: a Scottish charity, registration No. SC013781